综合单细胞分析与实验验证显示,ANXA2是炎症性肠病中铁亡的治疗标
Houshu Tu1, Menglin Chen1, Panpan Zhu2
1School of Clinical Medicine, Jiangxi University of Traditional Chinese Medicine Nanchang 330004, Jiangxi, China.
这项研究确定了附件A2 (ANXA2) 作为炎症性肠病 (IBD) 进展的关键标. 向纤维细胞中的ANXA2可能通过调节铁和炎症来为IBD提供一种新的治疗策略.
科学领域:
- 胃肠病学 胃肠病学
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 炎症性肠病 (IBD) 是一种慢性疾病,涉及肠道炎症.
- 铁,一种编程细胞死亡的形式,在IBD病变发生过程中起着重要作用.
- 确定IBD中铁亡的有效治疗点仍然是一个至关重要的未满足需求.
研究的目的:
- 确定与炎症性肠病中的铁死相关的新疗法标.
- 在IBD的背景下调查附件A2 (ANXA2) 在ferroptosis和炎症中的作用.
主要方法:
- 单细胞RNA测序数据分析 (GSE134809),包括基因组分数,细胞间通信和hdWGCNA.
- 在实验室验证使用细胞培养模型与ANXA2沉默或过度表达,采用RT-qPCR,西部涂抹,流细胞计和ELISA.
- 在硫酸 (DSS) 诱导的IBD小鼠模型中的体内验证,用于ANXA2,COL1A2和4-HNE的免疫光染色.
主要成果:
- 纤维细胞,特别是Fibro_2亚群,被确定为铁亡的关键参与者,ANXA2成为核心目标.
- 在体外,安克萨2沉默降低了铁,氧化应激和炎症标志物 (IL-6,CXCL8).
- 在IBD小鼠结肠组织中,ANXA2被上调,与纤维细胞标记物COL1A2和铁亡标记物4-HNE共定位.
结论:
- 附录素A2 (ANXA2) 在纤维细胞中显著表达,并与IBD中的ferroptosis有关.
- ANXA2代表了一种有前途的新型治疗点,用于治疗炎症性肠病.
更多相关视频
07:45Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases
Published on: September 1, 2017
04:01Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Reliability and Validity
